Review highlights how QbD improves product safety in parenteral formulations, suggesting better outcomes.
The review concludes that QbD implementations in parenteral formulation increase the quality of the product. It also states that the safety of parenteral products can be ensured by considering factors such as contamination, particle size, osmolarity, and others when designing the formulation.
No takes yet. Share an insight, caveat, or question.
Thakur et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: